Biotech firm reports divisional growth and revenues of £138m
AIM-listed Sheffield biotech firm Benchmark Holdings has posted revenues of £138m and an increased EBITDA of £10m in its latest trading update.
The firm said that its revenues of £138m were in line with market expectations. Adjusted EBITDA stands at £10m, ahead of the company’s guidance of £8.7m-£9.3m provided in September.
They added that the improved results had been driven by positive trading in Genetics and Advanced Nutrition, and lower bonus accruals, partially offset by forex movements, Animal Health and lumpf... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
